PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 15003605

Monitoring protein modification with allosteric ribozymes.

Narendra K Vaish·Karl Kossen·Lori E Andrews·Christopher Pasko·Scott D Seiwert
View original source ↗Export metadata ↓

Abstract

An allosteric ribozyme is an RNA-based enzyme (ribozyme) whose catalytic activity is modulated by molecular recognition of a protein. The direct coupling of a detectable catalytic event to molecular recognition by an allosteric ribozyme enables simple assays for quantitative protein detection. Most significantly, the mode of development and molecular recognition characteristics of allosteric ribozymes are fundamentally different from antibodies, providing them with functional characteristics that complement those of antibodies. Allosteric ribozymes can be developed using native proteins and, therefore, are often sensitive to protein conformation. In contrast, antibodies tend to recognize a series of adjacent amino acids as a consequence of antigen presentation and typically are not sensitive to protein conformation. Unlike antibody development, the development of allosteric ribozymes is a completely in vitro process that allows the specificity of an allosteric ribozyme to be tightly controlled. These significant differences from antibodies allow the pre-programmed development of conformation-state-specific protein detection reagents that can be used to investigate the activation-state of signal transduction components.

Explore related subjects

Allosteric RegulationAllosteric SiteBase SequenceCatalysisCloning, MolecularDNA, ComplementaryDNA-Directed RNA PolymerasesDirected Molecular EvolutionFluorescence Resonance Energy TransferGene LibraryKineticsModels, ChemicalModels, MolecularNucleic Acid ConformationPolymerase Chain ReactionProtein BindingProtein ConformationProteinsRNARNA, CatalyticViral ProteinsJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Narendra K Vaish, Karl Kossen, Lori E Andrews, Christopher Pasko, Scott D Seiwert. 2004. Monitoring protein modification with allosteric ribozymes.. https://doi.org/10.1016/j.ymeth.2003.10.005

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2026

Design and optimization of a kinase-controlled allosteric switch.

Post-translational control enables rapid and precise regulation of cell behavior. Despite these advantages, general strategies to build phosphorylation-based synthetic circuits are limited. Here we reasoned that engineered allostery, a technique that has been applied to design light- and chemically gated protein switches, could also be used to engineer phosphorylation-controlled protein switches (phospho-switches). Using an allosterically controllable Gal4 transcription factor as a scaffold, we show that a classic kinase Förster resonance energy transfer biosensor architecture can be used as a starting point for phospho-switch design. We optimize all features of the phospho-switch to develop an ERK-controlled transcription factor with a 20-fold phosphorylation-dependent change in transcriptional output. The resulting synthetic ERK-responsive transcription factor responds with comparable sensitivity to the c-fos promoter and reveals spatial ERK signaling patterns in mammalian developmental organoids. We further show that our switch architecture can be generalized to other input kinases and allosterically controlled targets. This work provides a general platform for a new generation of kinase-responsive tools for biosensing and synthetic biology applications.

Allosteric Regulation↗
PubMed2007

Allosteric activation of the extracellular Ca2+-sensing receptor by L-amino acids enhances ERK1/2 phosphorylation.

The calcium-sensing receptor (CaR) mediates feedback control of Ca2+o (extracellular Ca2+) concentration. Although the mechanisms are not fully understood, the CaR couples to several important intracellular signalling enzymes, including PI-PLC (phosphoinositide-specific phospholipase C), leading to Ca2+i (intracellular Ca2+) mobilization, and ERK1/2 (extracellular-signal-regulated kinase 1/2). In addition to Ca2+o, the CaR is activated allosterically by several subclasses of L-amino acids, including the aromatics L-phenylalanine and L-tryptophan. These amino acids enhance the Ca2+o-sensitivity of Ca2+i mobilization in CaR-expressing HEK-293 (human embryonic kidney) cells and normal human parathyroid cells. Furthermore, on a background of a physiological fasting serum L-amino acid mixture, they induce a small, but physiologically significant, enhancement of Ca2+o-dependent suppression of PTH (parathyroid hormone) secretion. The impact of amino acids on CaR-stimulated ERK1/2, however, has not been determined. In the present study, we examined the effects of L-amino acids on Ca2+o-stimulated ERK1/2 phosphorylation as determined by Western blotting and a newly developed quantitative assay (SureFire). L-Amino acids induced a small, but significant, enhancement of Ca2+o-stimulated ERK1/2. In CaR-expressing HEK-293 cells, 10 mM L-phenylalanine lowered the EC50 for Ca2+o from approx. 2.3 to 2.0 mM in the Western blot assay and from 3.4 to 2.9 mM in the SureFire assay. The effect was stereoselective (L>D), and another aromatic amino acid, L-tryptophan, was also effective. The effects of amino acids were investigated further in HEK-293 cells that expressed the CaR mutant S169T. L-Phenylalanine normalized the EC50 for Ca2+o-stimulated Ca2+i mobilization from approx. 12 mM to 5.0 mM and ERK1/2 phosphorylation from approx. 4.6 mM to 2.6 mM. Taken together, the data indicate that L-phenylalanine and other amino acids enhance the Ca2+o-sensitivity of CaR-stimulated ERK1/2 phosphorylation; however, the effect is comparatively small and operates in the form of a fine-tuning mechanism.

Allosteric Regulation↗
PubMed2007

Tripodal, cooperative, and allosteric transphosphorylation metallocatalysts.

Three artificial amino acids derived from l-serine by replacing the hydroxyl moiety with 1,4,7-triazacyclononane, 1,5,9-triazacyclododecane, and 1,4,7,10-tetraazacyclododecane, respectively, have been connected to the three arms of the tetraamine tris(2-aminoethyl)amine, Tren, to obtain tripodal ligands. They are able to bind up to four metal ions (like CuII and ZnII), three with the polyazamacrocycles and one with the Tren platform. Some of the ZnII complexes of these tripodal ligands proved to be good catalysts for the cleavage of the RNA model substrate 2-hydroxypropyl-p-nitrophenylphosphate (HPNP). Studies of the catalytic activity in the presence of increasing amounts of ZnII show that the complexes represent minimalist examples of metallocatalysts with cooperativity between the metal centers and allosteric control by a metal ion. The Tren binding site constitutes the allosteric regulation unit, while the three ZnII-azacrown complexes provide the cooperative, catalytic site. The allosteric role of the ZnII ion located in the Tren binding site was unambiguously demonstrated by studying the catalytic activity of a derivative unable to complex ZnII in that site. In this case, the cooperativity between the three ZnII ions bound to the peripheral azacrowns was totally suppressed. The kinetic analysis has shown that cooperativity is due to neither the occurrence of general-acid/general-base catalysis nor a decreased binding of the substrate because of the deprotonation of a water molecule bound to the complex but, rather, stabilization of the complexed substrate in its transformation into the transition state.

Allosteric Regulation↗